Revelation Biosciences Inc (REVB) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.33
• Market Cap: $3.54M
• EPS: $325.00
• 52-Week High: $46.31
• 52-Week Low: $1.29

Market Sentiment

Revelation Biosciences Inc currently has a Bullish sentiment score of 0.29.

About Revelation Biosciences Inc

Revelation Biosciences Inc. is a clinical-stage biopharmaceutical company headquartered in New York, focused on pioneering immunological diagnostics and therapeutics for disease prevention and treatment. The company leverages innovative research to harness the body's immune responses, aiming to address critical unmet medical needs through its promising product pipeline. As it progresses through clinical trials, Revelation Biosciences stands poised to make impactful contributions to the health...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Revelation Biosciences Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does REVB pay dividends?

Revelation Biosciences Inc (REVB) does not currently pay a regular dividend.

What is REVB's market cap?

Revelation Biosciences Inc (REVB) has a market capitalization of $3.54M with a current stock price of $1.33.